Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 7 | Cancer Cell International

Fig. 7

From: CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death

Fig. 7

Model of cell death mechanisms induced by CIB1 depletion alone or in combination with docetaxel/TRAIL. The combination of CIB1 targeting via RNA interference and docetaxel/TRAIL activates both apoptotic and non-apoptotic (paraptotic) signaling to induce TNBC-selective cell death and overcome chemo-resistance. Caspase-3/-8 activation and decreased Alix levels were used as markers of apoptosis and paraptosis, respectively

Back to article page